Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917072 · ClinicalTrials.gov registry record · NA
Innovative Strategies Which Improve the Clinical Handoff (I-SWITCH)
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT00917072: Completed NA study, sponsored by Henry Ford Health System.
NCT00917072 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00917072, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Study the feasibility of different educational modalities to improve resident handoff of patient information b) Determine whether different educational modalities (powerpoint vs. simulation workshop) lead to improved educational and (surrogate) clinical outcomes 1. Educate residents on the content and process of quality handoffs (Medical Knowledge) 2. Educate residents on good communication skills (Communication competency) 3. Improve perceived continuity of patient care, decrease adverse events related to transfer of care. (Patient safety competency) 4. Increase providers (night residents) satisfaction with the continuity of care during handoffs. (system-based practice/ Practice-based learning)
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Didactic
- BEHAVIORAL Didactic+Simulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-01 |
| Phase | NA |
What the finished NCT00917072 record still lists
NCT00917072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT00917072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00917072 about?
NCT00917072 is a clinical study titled "Innovative Strategies Which Improve the Clinical Handoff (I-SWITCH)". Study the feasibility of different educational modalities to improve resident handoff of patient information b) Determine whether different educational modalities (powerpoint vs. simulation workshop) lead to improved educational and (surrogate) clinical outcomes 1. Educate residents on the content ...
What is the current status of trial NCT00917072?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2007-09. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00917072?
The interventions under investigation include: Control (BEHAVIORAL), Didactic (BEHAVIORAL), Didactic+Simulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00917072?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00917072's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia